Document is current
Any future updates will be listed below
-
Authors
Ushio, Yusuke
Wakiya, Risa
Shimada, Hiromi
Sugihara, Koichi
Omura, Satoshi
Nakagomi, Daiki
Abe, Yoshiyuki
Wada, Makoto
Takizawa, Naoho
Nomura, Atsushi
Kukida, Yuji
Kondo, Naoya
Takagi, Hirosuke
Endo, Koji
Hirata, Shintaro
Azuma, Naoto
Takeuchi, Tohru
Fukui, Shoichi
Kamada, Kazuro
Yanai, Ryo
Matsuo, Yusuke
Shimojima, Yasuhiro
Nishioka, Ryo
Okazaki, Ryota
Takata, Tomoaki
Moriyama, Mayuko
Takatani, Ayuko
Miyawaki, Yoshia
Shirai, Tsuyoshi
Ito, Takafumi
Matsumoto, Isao
Takada, Toshihiko
Ito-Ihara, Toshiko
Kida, Takashi
Yajima, Nobuyuki
Kawaguchi, Takashi
Kawahito, Yutaka
Dobashi, Hiroaki
- License Information
-
More Information
Article History
Received: 29 November 2025
Accepted: 24 February 2026
First Online: 10 March 2026
Declarations
:
: This study was approved by the Ethics Committee of the Faculty of Medicine, Kagawa University (approval number: 2025-067), and was conducted in accordance with the principles of the Declaration of Helsinki. The Ethics Committee of the Faculty of Medicine at Kagawa University waived the need for written informed consent due to the retrospective nature of the study.
: Not applicable.
: SO has received honoraria for speakers bureaus from Janssen, UCB Japan, and Chugai. DN has received honoraria for speakers bureaus from AbbVie, Asahi Kasei, Eisai, and Taisho. SH has received research grants and honoraria for speakers bureaus from AbbVie, Asahi Kasei, Astellas, AstraZeneca, Ayumi, Boehringer Ingelheim, Bristol-Myers Squibb, Chugai, Daiichi Sankyo, Eisai, Eli Lilly, Gilead, GlaxoSmithKline, Janssen, Mitsubishi Tanabe, Nihon Shinyaku, Novartis, Otsuka, Pfizer, Taisho, and UCB Japan. NA has received research grants from Asahi Kasei and Chugai, and honoraria for speakers bureaus from Eli Lilly. MM has received honoraria for speakers bureaus from Asahi Kasei, Astellas, Ayumi, Eisai, Eli Lilly, Taisho, and Mitsubishi Tanabe. ToI has received honoraria for speakers bureaus from Kissei. YKa has received research grants and honoraria for speakers bureaus from Asahi Kasei, Ayumi, Chugai, Kissei, Novartis, and Pfizer. The other authors declare that they have no competing interests.
